
Parallel Health combines skin microbiome testing, personalized phage skincare, and dermatology consultations.
Parallel Health combines microbial measurement with targeted formulation and clinical oversight. Its CPD-01 page describes isolating a patient's bacterial strain and developing a matching phage, giving the service a defined pathway for cases beyond its existing biobank.
The same pathway includes continued support and repeat testing, allowing the company to connect formulation decisions with later assessments. Its California insurance participation offers an additional access route for eligible patients, subject to their individual plan and clinical evaluation.
Source: parallelhealth.io
Parallel Health operates both a consumer skincare storefront and a clinician-led care pathway. These channels expose customers to different forms of purchase: individual products, subscription protocols, and clinically evaluated prescriptions or custom phage development.
The operational distinction between a biobank match and new phage development is material. The CPD-01 page gives custom development a three-to-twelve-month timeframe, making its service workflow different from the foundational protocol and conventional immediate shipment of skincare products.
Source: parallelhealth.io
The MD-03 page separates the initial test and clinical consultation from continuing serum deliveries. Its published schedule lists an initial skin test at $195, a consultation stage at $195, and a first personalized serum at $195 per month.
Additional serums are listed at $95 per month, while active members receive complimentary retesting after six deliveries and discounts on other products. This structure ties continuing revenue to topical delivery while bundling repeated measurement and clinical support into membership.
Source: parallelhealth.io